• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Disothiazide 25
    / Dexcel


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 × 25mg

    full basket chart 56306 4344

    Related information


    Dosage

    High blood pressure: The initial dose is 12.5 – 25 mg HCTZ/day. The long-term dose is usually 12.5 mg HCTZ/day.
    Cardiac/hepatic/renal edema: The initial dose is 25 mg or 50 mg HCTZ/day. The long-term dose is usually 25 – 100 mg HCTZ/day.
    Patients with impaired cardiac/liver/kidney function: Dose should be adjusted.
    Elderly (above 65 years old): Attention should be paid to possible restrictions to kidney function. See lit.


    Indications

    Hypertension, edema.


    Contra-Indications

    Hypersensitivity to HCTZ or to any of the other ingredients of the medicine, other thiazides or other sulfonamidebased preparations; severe disturbances in kidney function (renal insufficiency with oliguria or anuria); glomerulonephritis; severe liver impairment like liver failure with impaired consciousness (coma and hepatic precoma); hypokalaemia; hyponatraemia; hypovolaemia; hypercalcaemia; high uric acid levels in the blood which are causing symptoms (patients with a history of gout); gout; breastfeeding.


    Special Precautions

    For additional information, please contact the license holder.


    Side Effects

    For additional information, please contact the license holder.


    Drug interactions

    For additional information, please contact the license holder.


    Pregnancy and Lactation

    For additional information, please contact the license holder.


    Overdose

    For additional information, please contact the license holder.


    Manufacturer
    Dexcel Ltd.
    Licence holder
    CLOSE